Prognostic Effects of Serum Vitamin D Levels in Patients with Breast Cancer
Keywords:
25 hydroxyvitamin D, breast cancer, prognosisAbstract
Low vitamin D level has been found on breast cancer risk. However, there were only few studies reported on their prognostic impact. Therefore, this study aimed to determine the effect of serum vitamin D level on breast cancer prognosis. Serum hydroxy vitamin D level was detected in 302 cases of breast cancer diagnosed during 2011-2018 at National Cancer Institute, using high performance liquid chromatography (HPLC) method. Our findings demonstrated that high level of 25(OH) vitamin D (>16ng/mL) was mainly found in the patients with early stage of breast cancer (P=0.042). Our findings suggested that low level of vitamin D might correlate with poor prognosis of breast cancer.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
Imsamran W, Chaiwerawattana A, Wiangnon S, Pongnikorn D, Suwanrungrung K, Sangrajrang S, et al. Cancer in Thailand. Vol VIII, 2010-2012. Bangkok: 2015.
Chaiwerawattana A, Loawahutanon P, SuwankasonP. Hospital-based cancer registry annual report 2012. Bangkok: Eastern Printing Public Company Limited PCL.157; 2014.
Dumitrescu RG, Cotarla I. Understanding breast cancer risk- Where do we stand in 2005? J Cell Mol Med 2005;9:208-21.
Holick MF, Frommer JE, McNeill SC, Richtand NM, Henley JW, Potts JT. Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun 1977;76:107-14.
Okano T, Yasumura M, Mizuno K, Kobayashi T. In vivo and in vitro conversion of 7-dehydrocholesterol into vitamin D3 in rat skin by ultraviolet ray's irradiation. J Nutr Sci Vitaminol (Tokyo) 1978;24: 47-56.
Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 1997;277:1827-30.
Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 2008;88:133-9.
Neyestani TR, Gharavi A, Kalayi A. Determination of Serum 25-hydroxy Cholecalciferol Using HighPerformance Liquid Chromatography: A Reliable Tool for Assessment of Vitamin D Status. Int J Vitam Nutr Res 2007;77:341-6.
Palmieri C, MacGregor T, Girgis S, Vigushin D. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol 2006;59: 1334-6.
Freedman DM, Looker AC, Chang S-C, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594-602.
Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 2008;88:133-9.
Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, et al. Association of serum level of vitamin D at diagnosis with breast cancer survival: a casecohort analysis in the pathways study. JAMA Oncol 2017;3:351-7.
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008;100:1581-91.
Lohmann AE, Chapman JA, Burnell MJ, Levine MN, Tsvetkova E, Pritchard KI, et al. Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Breast Cancer Res Treat 2015;150:605-11.
Mohr SB, Gorham ED, Kim J, Hofflich H, Garland CF. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res 2014;34:1163-6.
Thanasitthichai S, Chaiwerawattana A, Prasitthipayong A. Association of Vitamin D Level with Clinicopathological Features in Breast Cancer. Asian Pac J Cancer Prev 2015;16:4881-3.
Vrieling A, Hein R, Abbas S, Schneeweiss A, FleschJanys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 2011;13:R74.
Hu K, Callen DF, Li J, Zheng H. Circulating vitamin D and overall survival in breast cancer patients: a doseresponse meta-analysis of cohort studies. Integr Cancer Ther 2018;17:217-25.
de Sousa Almeida-Filho B, De Luca Vespoli H, Pessoa EC, Machado M, Nahas-Neto J, Nahas EAP. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women. J Steroid Biochem Mol Biol 2017;174:284-9.
Buono G, Giuliano M, De Angelis C, Lauria R, Forestieri V, Pensabene M, et al. Pretreatment serum concentration of vitamin D and breast cancer characteristics: a prospective observational mediterranean study. Clin Breast Cancer 2017; 17:559-63.
Downloads
Published
Issue
Section
License
บทความทีตีพิมพ์ในวารสารโรคมะเร็งนี้ถือว่าเป็นลิขสิทธิ์ของมูลนิธิสถาบันมะเร็งแห่งชาติ และผลงานวิชาการหรือวิจัยของคณะผู้เขียน ไม่ใช่ความคิดเห็นของบรรณาธิการหรือผู้จัดทํา
